INVESTOR ALERT: Edelson Lechtzin LLP is Investigating Securities Fraud Claims on Behalf of Tuya, Inc. (NYSE: Tuya) Shareholders
NEWTOWN, PA, August 16, 2022 — The law firm of Edelson Lechtzin LLP is investigating securities fraud claims on behalf of all purchasers of Tuya Inc (“Tuya” or the “Company”) (NYSE: TUYA) pursuant and/or traceable to the registration statement and related prospectus issued in Tuya American Depositary Shares (“ADSs”) in or traceable to Tuya’s March 2021 initial public offering (the “IPO). This lawsuit is seeking to pursue remedies under the Securities Act of 1933.
Investors who purchased Tuya Inc. common stock during the Class Period may move the U.S. District Court for the Southern District of New York to appoint them as lead plaintiff, no later than October 11, 2022. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Investors who wish to discuss the lead plaintiff selection process should contact Edelson Lechtzin LLP, toll free at 844-696-7492, or by e-mail at [email protected]elson-law.com. A copy of the class action complaint can be viewed here.
Background on the Tuya Inc. Securities Class Action
Tuya is a China based technology company that developed and offers a purpose-built “Internet of Things” (“IoTs”) cloud platform that delivers offerings that include Platform-as-a-Service (“PaaS”) and Software-as-a-Service (“SaaS”) to business and developers. Tuya’s products and services enable so-called “smart devices,” e.g., household items and appliances connected to the internet, to communicate and interact with end uses and online information and services.
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving securities and investment fraud, our lawyers focus on class and collective litigation in cases alleging violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and dangerous and defective drugs and medical devices.
For more information, please contact:
Marc H. Edelson, Esq.
Eric Lechtzin, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Email: [email protected]